Telomir Pharmaceuticals, Inc.'s total assets for Q3 2025 were $7.40M, an increase of 792.24% from the previous quarter. TELO total liabilities were $422.81K for the fiscal quarter, a 21.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.